Navin Fluorine International Limited — Others, 25-08-2025: Change in Management

Navin Fluorine International announces a leadership transition in its CDMO Business. Mr. Rajendra Sahu, the current CEO, has resigned, effective September 20. Dr. Vijay Kaiwar has been appointed as the new CEO Designate, taking full charge from September 21. Dr. Kaiwar brings nearly 30 years of extensive experience in CDMO and API segments, having held senior leadership roles across R&D, operations, and business development at various global pharmaceutical companies. His expertise in chemistry, biotechnology, and diverse technologies is expected to strengthen the company's critical CDMO growth trajectory and client partnerships.